Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility

Journal of Cell Biology

Volumn 137, Issue 3, 1997, Pages 779-791

  Franco, Paola ^a   Iaccarino, Ciro ^a   Chiaradonna, Ferdinando ^a   Brandazza, Anna ^b   Iavarone, Carlo ^a   Mastronicola, M Rosaria ^a,d   Luisa Nolli, M ^c   Stoppelli, M Patrizia ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b PFIZER INC   (United States)

^c Gruppo Lepetit SpA   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; SERINE; UROKINASE;

AMINO ACID SUBSTITUTION; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CHEMOTAXIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; ENZYME PRECURSORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES; GLUTAMATES; HUMANS; MOLECULAR SEQUENCE DATA; MONOCYTES; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PHOSPHOSERINE; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 0030907047     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.137.3.779     Document Type: Review

References (67)

1. Appella, E., E. Robinson, S. Ulrich, M.P. Stoppelli, A. Corti, G. Cassani, and F. Blasi. 1987. The receptor binding sequence of urokinase: biological function for the growth factor module of proteases. J. Biol. Chem. 262: 4437-4440.
2. Axelrod, J., R. Reich, and R. Miskin. 1989. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras transformed NIH 3T3 cells. Mol. Cell. Biol. 9:2133-2141.
3. Barlati, S., F. Paracini, D. Bellotti, and G. De Petro. 1991. Tyrosine phosphorylation of human urokinase plasminogen activator FEBS Lett. 281:137-140.
4. Barlati, S., G. De Petro, C. Bona, F. Paracini, and M. Tonelli. 1995. Tyrosine phosphorylation of human urokinase plasminogen activator. FEBS Lett. 363: 170-174.
5. Blasi, F., M. Conese, L.B. Moller, N. Pedersen, U. Cavallaro, M.V. Cubellis M.R. Soria, M.P. Stoppelli, D. Talarico, T. Teesalu, et al. 1994. The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis. 8:182-188.
6. Blasi, F., J.D. Vassalli, and K. Dano. 1987. Urokinase-type plasminogen activator: pro-enzyme, receptor, and inhibitors. J. Cell Biol. 104:801-804.
7. Bohuslav, J., V. Horejsi, C. Hansmann, J. Stockl, U.H. Weidle, O. Majdic, I. Bartke, W. Knapp, and H. Stockinger. 1995. Urokinase plasminogen activator receptor, β2-integrins, and Src kinases within a single receptor complex of human monocytes. J. Exp. Med. 181:1381-1390.
8. Bradford, M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
9. Buchman, A.R., and P. Berg. 1988. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:4395-4405.
10. Bush, G.L., A.M. Tassin, H. Friden, and D.I. Meyer. 1991. Secretion in yeast. Purification and in vitro translocation of chemical amounts of pre-pro-alpha factor. J. Biol. Chem. 266:13811-13814.
11. Busso, N., S.K. Masur, D. Lazega, S. Waxman, and L. Ossowsky. 1994. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126:259-270.
12. Carriero, M.V., S. Del Vecchio, P. Franco, O. Massa, G. Botti, M. Cerra, G. D'Aiuto, G. Esposito, M.P. Stoppelli, and M. Salvatore. 1994. Identification of receptor-bound urokinase in human malignant breast tumors. Cancer Res. 54:5445-5454.
13. Cao, D., I. Mizukami, B.A. Garni-Wagner, A.L. Kindzelskii, R.F. Todd II, L.A. Boxer, and H.R. Petty. 1995. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. J. Immunol. 154:1818-1829.
14. 2-macroglobulin receptor. J. Biol. Chem. 269: 17886-17892.
15. Cubellis, M.V., P. Andreasen, P. Ragno, M. Mayer, K. Dano, and F. Blasi. 1989. Accessibility of receptor-bound urokinase to type 1 plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA. 86:4828-4832.
16. Cubellis, M.V., T.C. Wun, and F. Blasi. 1990. Receptor-mediated internalizaiion and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO (Eur. Mol. Biol. Organ.) J. 9:1079-1085.
17. Dano, K., P.A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44:139-266.
18. Pano, K., N. Beherendt, N. Brunner, V. Ellis, M. Plough, and C. Pyke. 1994. The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis. 8:(suppl. 1):189-203.
19. Del Rosso, M., E. Anichini, N. Pedersen, F. Blasi, G. Fibbi, M. Pucci, and M. Ruggiero. 1993. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem. Biophys. Res. Commun. 190:347-352.
20. Del Vecchio, S., M.P. Stoppelli, M.V. Carriero, R. Fonti, O. Massa, P.Y. Li, G. Botti, M. Cerra, G. D'Aiuto, G. Esposito, et al. 1993. Human urokinase receptor concentration in malignant and benign breast tumours by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 53:3198-3206.
21. Dumler, I., T. Petri, and W.D. Schleuning. 1993. Interaction of urokinase-type plasminogen activator (uPA) with its cellular receptor induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett. 322:37-40.
22. Ellis, V., N. Beherendt, and K. Dano. 1991. Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266:12752-12758.
23. Ellis, V., M. Scully, and V. Kakkar. 1989. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264:2185-2188.
24. Estreicher, A., J. Muhlhauser, J.L. Carpentier, L. Orel, and J.D. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783-792.
25. Franco, P., M.R. Mastronicola, D. De Cesare, M.L. Nolli, T.C. Wun, P. Verde, F. Blasi, and M.P. Stoppelli. 1992. Separation and characterization of non phosphorylated and serine phosphorylated pro-urokinase. Catalytic properties and sensitivity to PAI-1. J. Biol. Chem. 267:19369-19372.
26. Gumbiner, B.M. 1996. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84:345-357.
27. Gyetko, M.R., R.F. Todd III, C.C. Wilkinson, and R.G. Sitrin. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380-1387.
28. Hansen, A.P., A.M. Petros, and R.P. Meadows. 1994. Solution structure of the amino-terminal fragment of the urokinase type plasminogen activator. Biochemistry. 33:4847-4864.
29. 2-macroglobulin. J. Biol. Chem. 266:12329-12336.
30. Hoeffler, W.K., A.D. Levinson, and E.A. Bauer. 1994. Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res. 22:1305-1312.
31. Huang, M.T.F., and C.M. Gorman. 1990. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18:937-947.
32. Hurley, J.H., A.M. Dean, J.L. Sohl, D.E. Koshland, and R.M. Stroud. 1990. Reeulation of an enzyme by phosphorylation at the active site. Science (Wash. DC). 249:1012-1016.
33. 2, CD11b/CD18) during neutrophil polarization. J. Immmunol. 156:297-309.
34. Kirchheimer, J.C., J. Woita, J. Christ, and B.R. Binder. 1989. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc. Natl. Acad. Sci. USA. 86:5424-5428.
35. Janknecht, R., G. de Martynoff, J. Lou, R.A. Hipskind, A. Nordheim, and H.G. Stunnenberg. 1991. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. USA. 88:8972-8976.
36. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
37. Lauffenburger, D.A., and A.F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell. 84:359-369.
38. Li, C., J.N. Liu, and V. Gurewich. 1995. Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyterminal lysine and cAMP dependent signal transduction. J. Biol. Chem. 270:30282-30285.
39. Liu, X., and J.E. Mertz. 1995. HnRNPL binds a cis-acting RNA sequence element that enables intron-independent gene expression. Genes Dev. 9:1766-1780.
40. Maciejewski, P.M., F.C. Peterson, P.J. Anderson, and C.J. Brooks. 1995. Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin. J. Biol. Chem. 270:27661-27665.
41. Mastronicola, M.R., M.P. Stoppelli, A. Migliaccio, F. Auricchio, and F. Blasi. 1990. Serine phosphorylation of biosynthetic pro-urokinase from human tumour cells. FEBS Lett. 266:109-114.
42. Mastronicola, M.R., P. Franco. D. De Cesare, O. Massa, and M.P. Stoppelli. 1992. Phosphorylation of urokinase is not a limiting step in biosynthesis but results in a reduced PAI-1 sensitivity. Fibrinolysis. 6:117-120.
43. Moser, T.L., J.J. Enghild, S.V. Pizzo, and M.S. Stack. 1995. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem. J. 307:867-873.
44. Myohanen, H.T., R.W. Stephens, K. Hedman, H. Tapiovaara, E. Ronne, G. Hoyer-Hansen, K. Dano, and A. Vaheri. 1993. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem. 41:1291-1301.
45. Nolli, M.L., A. Corti, A. Soffientini, and G. Cassani. 1986. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator. Thromb. Haemostasis. 56:214-218.
46. Nolli, M.L.. A. Corti, E. Sarubbi, and G. Cassani. 1989. Production and characterization of human single chain urokinase-type plasminogen activator from mouse cells. Fibrinolysis. 3:101-106.
47. Nusrat. A., and H.A. Chapman. 1991. An autocrine role for urokinase in phorbol-ester mediated differentiation of myeloid cell lines. J. Clin. Invest. 87: 1091-1097.
48. Orsini, G., A. Brandazza, P. Sarmientos, A. Molinari, J. Lansen, and G. Cauet. 1991. Efficient renaturation and fibrinolytic properties of pro-urokinase and a deletion mutant in E. coli as inclusion bodies. Eur. J. Biochem. 195:691-697.
49. Oswald, R.E., M.J. Bogusky, M. Bamberger, R.A. Smith, and C.M. Dobson. 1989. Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR. Nature (Lond.). 337:579-582.
50. Patthy, L. 1985. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell. 41:657-663.
51. Picone, R., E.K. Locatelli, L.S. Nielsen, M.R. Mastronicola, M.V. Cubellis, M.P. Stoppelli, and F. Blasi. 1989. Phorbol ester PMA regulates the affinity and the number of the urokinase receptors in monocyte-like U937 cells. J. Cell Biol. 108:693-702.
52. Plough, M., V. Ellis, and K. Dano. 1994. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry. 33:8991-8997.
53. Resnati, M., M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO (Eur. Mol. Biol. Organ.) J. 15:1572-1582.
54. Riccio, A., G. Grimaldi, P. Verde, G. Sebastio, S. Boast, and F. Blasi. 1985. The human urokinase plasminogen activator gene and its promoter. Nucleic Acids Res. 13:2759-2771.
55. Robinson, P.J. 1991. Signal transduction by GPI-anchored membrane proteins. in GPI Membrane Anchors. M.L. Cardoso de Almeida, editor. Academic Press Inc., San Diego. CA. pp. 22-28.
56. Roldan, A., M.V. Cubellis, M.T. Masucci, N. Beherendt. L.R. Lund, K. Dano, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO (Eur. Mol. Biol. Organ.) J. 9:467-474.
57. Rolley, N., and J. Milner. 1994. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site. Oncogene. 9:3067-3070.
58. Sitrin, R.G., R.F. Todd, E. Albrecht, and M.R. Gyetko. 1996. The urokinase receptor CD 87 facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97:1942-1951.
59. Stephens, R.W., J. Pollanen, H. Tapiovaara, K.C. Leung, P.S. Sim, E.M. Salonen, E. Ronne, L.N. Behrend, K. Dano, and A. Vaheri. 1989. Activation of pro-urokinase and plasminogen on human fibrosarcoma cells. A proteolytic system with surface-bound reactants. J. Cell Biol. 108:1987-1995.
60. Stoppelli, M.P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R.K. Assoian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes, Proc. Natl. Acad. Sci. USA. 82:4939-4943.
61. Stoppelli, M.P., C. Tacchetti, M.V, Cubellis, A. Corti, V.J. Hearing, G. Cassani, E. Appella, and F. Blasi. 1986. Autocrine saturation of pro-urokinase receptors. Cell. 45:675-684.
62. Takahashi, K., H.C. Kwaan, E. Koh, and M. Tanabe. 1992. Enzymatic properties of the phosphorylated urokinase-type plasminogen activator isolated from a human carcinomatous cell line. Biochem. Biophys. Res. Commun. 182:1473-1481.
63. r 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100: 86-92.
64. Waltz, D.A., L.Z. Sailor, and H.A. Chapman. 1993. Cytokines induce urokinase-dependent adhesion of human myeloid cells: a regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91:1541-1552.
65. We, Y., D.A. Waltz, N. Rao, R.J. Drummond, S. Rosenberg, and H.A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
66. Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science (Wash. DC). 273:1551-1555.
67. Fak): a point of convergence in the action of neuropeptides, integrins and oncogenes. Cell. 71:891-894.